Imara Inc.
http://www.imaratx.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Imara Inc.
Finance Watch: Restructurings, Layoffs Reflect Ongoing Uncertainty In Biotech
Sio Gene, Genocea, Solid Biosciences, Saniona and Black Diamond join First Wave, Zosano, Vallon, Finch, Magenta, ProQR and Imara on the growing list of biopharma firms reducing headcount to make their cash last until valuations return to a level that may support new fundraising.
ICER Will Explore Link Between Reasonable Drug Pricing And ‘Fair’ US Formulary Policies
Study will examine prior authorization and other access restrictions at 15 of the largest US commercial payers for a group of 27 drugs.
ICER Study On Coverage 'Fairness' Could Inform Manufacturer Pricing vs Benefit Design Debate
Study will look at prior authorization, step therapy and required medication switching for drugs considered to be reasonably priced.
IPO Year In Review: Record-Year Bodes Well For 2021, And For More SPACs
Biopharma was an attractive investment in 2020 and fundamentals are unchanged in 2021, including the pandemic’s work-at-home requirements, which allowed more companies to go public faster.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals